Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 3661 AL 3675

Organic Fluorophores Conjugated with Pyridinium Acceptor: A Review on Design, Synthesis, and Application in Mitochondrial Imaging

Debnath P.

Curr Pharm Des. 2026;32(13):971-1001. doi: 10.2174/0113816128395084250708080830.

The Expanding Role of Non-Coding RNAs in Neurodegenerative Diseases: From Biomarkers to Therapeutic Targets

Zhao X, Zheng Y, Cai X, Yao Y, Qin D.

Pharmaceuticals (Basel). 2026 Jan 3;19(1):92. doi: 10.3390/ph19010092.

Mechanistic research and therapeutic prospects of alternative splicing in neurodegenerative diseases

Ran X, Wang M, Huang J, Kuang N, Tian P, Wu J, Feng F, Luo Y, Huang N.

Ageing Res Rev. 2026 Jun;118:103133. doi: 10.1016/j.arr.2026.103133. Epub 2026 Apr 8.

Leucine-Rich Repeat Kinase 2 (LRRK2) in Glucose Metabolism and Metabolic-Neuroinflammatory Crosstalk

Kawakami F, Imai M, Ogata M, Habata T, Tamaki S, Kawashima R, Kurosaki Y, Miyai S, Chatatikun M, Kyaw MP, Ohba K.

Biomolecules. 2026 Apr 15;16(4):588. doi: 10.3390/biom16040588.

Preventing Parkinson's disease in the context of movement disorders: a narrative review of current evidence and future directions

Schaeffer E, Becktepe JS, Brockmann K, Eggers C, Gülke E, Kalbe E, Rattay TW, Tönges L, Warnecke T, Zeuner KE, Berg D.

Neurol Res Pract. 2026 Apr 20;8(1):27. doi: 10.1186/s42466-026-00488-2.

[MRI in neurodegenerative Parkinsonian syndromes]

Schröter N, Rau A, Reith W, Martens D, Gonzalez-Escamilla G, Groppa S.

Radiologie (Heidelb). 2026 Apr;66(4):241-248. doi: 10.1007/s00117-026-01585-8. Epub 2026 Feb 27.

Acupuncture: A Promising Non-Pharmacological Approach to Parkinson's Disease Management

Wu XC, Dong YY, Ying YC, Yin P, Chen YL.

Brain Behav. 2026 Apr;16(4):e71438. doi: 10.1002/brb3.71438.

Environmental Substances Associated with Neurodegeneration: An Overview of Parkinson's Disease and Related Genotoxic Endpoints

Shoeb M, Alman B, Kaur H, Han M, Atif F, Kim WW, Desai S, Ruiz P, Zarus GM.

Genes (Basel). 2026 Feb 13;17(2):236. doi: 10.3390/genes17020236.

Advanced Therapeutics in Parkinson's Disease: What's New?

Monje MHG, Karl JA, Cooper CS, Yomtoob J, Deliz J, Morse LA, Shetty N, Verhagen Metman L.

Curr Neurol Neurosci Rep. 2026 Feb 18;26(1):11. doi: 10.1007/s11910-026-01483-5.

Neuronal vulnerability in Parkinson's disease: insights from murine α-synuclein pathology models

Asadpoordezaki Z, Prehn JHM.

Neuroscience. 2026 Jun 22;605:73-90. doi: 10.1016/j.neuroscience.2026.04.007. Epub 2026 Apr 17.

The Impact of Inspiratory Muscle Strength Training on Vocal Loudness in Individuals With Parkinson's Disease: A Pilot Study

McClutchy C, Herndon N, Mir M, Anderson A, Wheeler-Hegland K.

J Voice. 2026 Jan 7:S0892-1997(25)00531-4. doi: 10.1016/j.jvoice.2025.12.008. Online ahead of print.

Nanomedicines for neurodegenerative ageing: nasal delivery innovations for Alzheimer's and Parkinson's disease

Upadhyay R, Jain A, Karthik T, Desavathu M.

J Drug Target. 2026 Apr 27:1-20. doi: 10.1080/1061186X.2026.2659210. Online ahead of print.

Resting-State EEG Features of Cognitive Fluctuations Across the Lewy Body Disease Spectrum

Negida A, Lageman SK, Ono K, Ahsan MM, Mukhopadhyay N, Barrett MJ.

Res Sq [Preprint]. 2026 Mar 31:rs.3.rs-9193762. doi: 10.21203/rs.3.rs-9193762/v1.

Immunotherapies for risk reduction in age-associated neurodegenerative diseases: impact of sex and treatment duration

Cortes-Flores H, Torrandell-Haro G, Brinton RD.

medRxiv [Preprint]. 2026 Mar 6:2026.03.06.26347446. doi: 10.64898/2026.03.06.26347446.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias